Hepatitis, Viral, Human
Information
- Disease name
- Hepatitis, Viral, Human
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00000580 | Completed | Phase 3 | Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin | November 1975 | June 1986 |
NCT00000583 | Completed | Phase 3 | Hepatitis B Vaccine Clinical Trial | November 1978 | June 1980 |
NCT00005304 | Completed | Delta Hepatitis and Liver Disease in Hemophiliacs | September 1986 | September 1991 | |
NCT00005305 | Completed | Hepatitis Delta Infections in Hemophiliacs | September 1987 | September 1991 | |
NCT00005306 | Completed | Natural History of Post-transfusion Non-A, Non-B Hepatitis | March 1988 | September 2001 | |
NCT00005309 | Completed | Prospective Study of HIV Infection in Hemophiliacs | July 1990 | March 1995 | |
NCT00005339 | Completed | Risk of Post Transfusion Hepatitis C Virus Infection | February 1992 | April 2004 | |
NCT00007371 | Completed | Hepatitis C in Clinically Discordant Hemophilic Siblings | September 1999 | August 2004 | |
NCT00029406 | Completed | Transfusion Infections Pediatric Prospective Study (TRIPPS) | April 2001 | April 2013 | |
NCT00097006 | Completed | Retrovirus Epidemiology Donor Study-II (REDS-II) | September 2004 | September 2009 | |
NCT00116454 | Completed | Phase 3 | Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis | July 2005 | August 2013 |
NCT00230854 | Completed | Phase 1 | Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin | August 2005 | July 2007 |
NCT01170741 | Completed | Phase 1 | Computer-Assisted Tailored Cue-card Health [CATCH] Study | June 2010 | June 2012 |
NCT01532973 | Completed | Phase 1 | Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) | February 16, 2012 | May 17, 2013 |
NCT01804829 | Completed | Phase 3 | Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. | June 2013 | June 2016 |
NCT03410953 | Completed | Phase 4 | Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines | April 13, 2018 | October 31, 2019 |
NCT00342186 | Completed | Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | September 27, 2002 | February 22, 2018 | |
NCT00564811 | Completed | N/A | Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) | March 2003 | September 2004 |
NCT00608192 | Completed | N/A | HIV and Hepatitis Care Coordination in Methadone Treatment | January 2008 | June 2011 |
NCT00913757 | Completed | A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area | July 1, 2009 | May 1, 2020 | |
NCT00915057 | Completed | Phase 2 | Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. | March 2009 | March 2009 |
NCT01163240 | Completed | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | June 2009 | ||
NCT05492565 | Enrolling by invitation | Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis | January 1, 2020 | December 31, 2030 | |
NCT00318682 | Terminated | Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis | May 2006 | August 2008 | |
NCT02613403 | Terminated | Phase 2 | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) | December 10, 2015 | March 27, 2017 |
NCT03776760 | Unknown status | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination | May 28, 2019 | August 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006525